Author: Laila Zulfa

In a development that could fundamentally alter the management of Type 2 diabetes for millions of Americans, a landmark study published in the New England Journal of Medicine has provided robust clinical evidence supporting the use of continuous glucose monitoring (CGM) systems for patients who do not require insulin. The study, known as the CONNECT…

The global healthcare landscape watched closely as Johnson & Johnson (J&J) released its third-quarter financial results, revealing a Medtech segment that, while growing, failed to meet the ambitious internal benchmarks set by the New Jersey-based conglomerate. For the period ending September 30, the medical technology division reported total sales of $8.64 billion, marking a 2.5%…

Steris, a global leader in infection prevention and surgical technologies, has entered into a definitive agreement to acquire Xodus Medical in a transaction valued at approximately $2.1 billion. This landmark deal represents a significant escalation in the company’s mergers and acquisitions strategy, moving beyond the smaller "tuck-in" acquisitions that characterized its previous fiscal cycles. By…

Sava Technologies, a London-based medical technology innovator, has successfully closed a $36 million Series B funding round, marking a significant milestone in the development of next-generation wearable health monitors. The funding round was bolstered by a strategic partnership and exclusive sales agreement with Ascensia Diabetes Care, a global leader in diabetes management solutions. This capital…

The healthcare technology sector is currently grappling with a critical safety concern involving the Philips Lumify diagnostic ultrasound system, a portable medical device that has become a staple in emergency and remote clinical settings. A significant software malfunction has been identified that can render the device inoperable at the exact moment it is needed most:…

Medical Microinstruments (MMI), a pioneer in the field of robotic microsurgery, has announced the successful completion of a new financing round intended to accelerate the commercialization of its Symani Surgical System and propel high-stakes clinical research into neurodegenerative conditions. Led by existing investor BioStar Capital, the funding round saw participation from S3 Ventures, Angelini Ventures,…

The rapid advancement of quantum computing technology has transitioned from a theoretical concept to a looming cybersecurity crisis for the global healthcare industry. As researchers and technology giants move closer to achieving "quantum supremacy"—the point at which a quantum computer can perform calculations impossible for classical machines—the foundational encryption protocols that protect sensitive patient data…

The Advanced Medical Technology Association, known as AdvaMed, has formally called upon the Centers for Medicare & Medicaid Services (CMS) to broaden the scope of its newly proposed "Regulatory Alignment for Predictable and Immediate Device" (RAPID) coverage pathway. In a comprehensive response to the agency’s latest regulatory framework, the industry’s leading lobbyist group emphasized that…

A United States District Court has finalized a significant financial penalty against Apple Inc., ruling that the technology giant must pay an additional $184.2 million in prejudgment interest to medical technology firm Masimo. This ruling follows a prior jury verdict that found Apple had infringed upon Masimo’s patented pulse oximetry technology, used to measure blood…

Boston Scientific Corporation has officially announced a significant evolution of its executive leadership team and organizational structure, naming Joseph Fitzgerald as the company’s new executive vice president and chief operating officer, effective January 1, 2027. This leadership transition marks a pivotal moment for the Marlborough, Massachusetts-based medical technology giant as it moves to streamline its…